Granite Point Capital Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-150,000
| Closed | -$1.81M | – | 129 |
|
2018
Q1 | $1.81M | Sell |
150,000
-92,113
| -38% | -$1.11M | 0.17% | 32 |
|
2017
Q4 | $2.68M | Hold |
242,113
| – | – | 0.26% | 18 |
|
2017
Q3 | $3.03M | Buy |
242,113
+125,000
| +107% | +$1.56M | 0.64% | 12 |
|
2017
Q2 | $1.33M | Hold |
117,113
| – | – | 0.33% | 42 |
|
2017
Q1 | $1.56M | Hold |
117,113
| – | – | 0.47% | 28 |
|
2016
Q4 | $1M | Buy |
117,113
+11,852
| +11% | +$101K | 0.8% | 39 |
|
2016
Q3 | $954K | Sell |
105,261
-7,415
| -7% | -$67.2K | 0.37% | 36 |
|
2016
Q2 | $891K | Buy |
+112,676
| New | +$891K | 0.38% | 43 |
|
2015
Q4 | $1.36M | Sell |
117,841
-10,000
| -8% | -$115K | 0.2% | 27 |
|
2015
Q3 | $1.33M | Sell |
127,841
-316
| -0.2% | -$3.29K | 0.91% | 26 |
|
2015
Q2 | $1.35M | Buy |
128,157
+3,157
| +3% | +$33.4K | 0.39% | 35 |
|
2015
Q1 | $1.55M | Buy |
+125,000
| New | +$1.55M | 0.57% | 29 |
|